SCHEMBL31700367

SCHEMBL31700367

O=S(=O)(Nc1ccc2ocnc2c1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN2 P17706 6/20 0.64
▸ PTPN1 P18031 6/20 0.64
▸ PTPN5 P54829 6/20 0.64
▸ HSPD1 P10809 4/20 0.64
▸ HSPE1 P61604 4/20 0.64
▸ HSD17B2 P37059 1/20 0.55
▸ TSHR P16473 1/20 0.54
▸ NR3C1 P04150 1/20 0.53
▸ PGR P06401 1/20 0.53
▸ AR P10275 1/20 0.53
▸ ESR2 Q92731 1/20 0.53
▸ KMT2A Q03164 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ TOP2A P11388 1/20 0.51
▸ CLK1 P49759 1/20 0.50
▸ HIF1A Q16665 1/20 0.49
▸ PIK3CB P42338 1/20 0.49
▸ HDAC1 Q13547 1/20 0.48
▸ HDAC8 Q9BY41 1/20 0.48
▸ MAPT P10636 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31701732 0.87 PTPN2 (0.61) PTPN2PTPN1PTPN5HSPD1HSPE1
SCHEMBL31702052 0.82 PTPN2 (0.61) PTPN2PTPN1PTPN5HSPD1HSPE1
SCHEMBL31700702 0.82 PTPN5 (0.61) PTPN2PTPN1PTPN5HSPD1HSPE1
SCHEMBL31700542 0.82 PTPN2 (0.61) PTPN2PTPN1PTPN5HSPD1HSPE1
SCHEMBL31702160 0.82 HSPD1 (0.61) PTPN2PTPN1PTPN5HSPD1HSPE1
SCHEMBL31701603 0.79 PTPN2 (0.64) PTPN2PTPN1PTPN5HSPD1HSPE1
SCHEMBL31700554 0.79 PTPN2 (0.64) PTPN2PTPN1PTPN5HSPD1HSPE1
SCHEMBL31701721 0.79 HSPD1 (0.64) PTPN2PTPN1PTPN5HSPD1HSPE1
SCHEMBL31700365 0.78 PTPN2 (0.59) PTPN2PTPN1PTPN5HSPD1HSPE1
SCHEMBL31700537 0.78 PTPN2 (0.63) PTPN2PTPN1PTPN5HSPD1HSPE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250319056-A1 METHODS FOR TREATING CANCER UNIV INDIANA TRUSTEES (US) 2025-10-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250319056-A1 METHODS FOR TREATING CANCER HSP90AB1, HSP90B1, HSP90AB2P PTPN2 2771/4885PTPN1 3070/4885PTPN5 2831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback